Fibronectin improves transduction of reconstituting hematopoietic stem cells by retroviral vectors: Evidence of direct viral binding to chymotryptic carboxy-terminal fragments

Thomas Moritz, Parmesh Dutt, Xiangli Xiao, Dirk Carstanjen, Terry Vik, Helmut Hanenberg, David A. Williams

Research output: Contribution to journalArticle

160 Citations (Scopus)

Abstract

Efficient transduction of reconstituting hematopoietic stem cells (HSC) is currently only possible by cocultivation of target cells directly on producer cell lines, a method not applicable to human gene therapy protocols. Our laboratory has previously shown adhesion of primitive hematopoietic stem and progenitor cells to the carboxy-terminal 30/35-kD fragment of the extracellular matrix molecule fibronectin (FN 30/35) (Nature 352:438, 1991) and increased transduction of human hematopoietic progenitor cells via retroviral vectors while adherent to this fragment (J Clin Invest 93:1451, 1994). Here we report that (1) transduction of reconstituting murine HSC assayed 12 months after infection with retrovirus supernatant on FN 30/35 is as effective as cocultivation directly on producer cells; (2) recombinant retrovirus particles directly adhere to FN 30/35 in a quantitative and dose-dependent fashion; and (3) increased transduction efficiency on FN 30/35 does not appear to be associated with increased cell proliferation or activation of protein phosphorylation typically induced by integrin-fibronectin interactions. Therefore, we speculate that supernatant infection of HSC on FN 30/35 leads to colocalization of retrovirus particles and target cells on FN 30/35 molecule with a large increase in local virus titer presented to the cell. These findings have direct and important implications for the modification of current human gene therapy protocols.

Original languageEnglish (US)
Pages (from-to)855-862
Number of pages8
JournalBlood
Volume88
Issue number3
StatePublished - Aug 1 1996
Externally publishedYes

Fingerprint

Hematopoietic Stem Cells
Stem cells
Fibronectins
Gene therapy
Phosphorylation
Molecules
Cell proliferation
Retroviridae
Coculture Techniques
Viruses
Integrins
Genetic Therapy
Adhesion
Chemical activation
Retroviridae Infections
Cells
Viral Load
Extracellular Matrix
Proteins
Cell Proliferation

ASJC Scopus subject areas

  • Hematology

Cite this

Fibronectin improves transduction of reconstituting hematopoietic stem cells by retroviral vectors : Evidence of direct viral binding to chymotryptic carboxy-terminal fragments. / Moritz, Thomas; Dutt, Parmesh; Xiao, Xiangli; Carstanjen, Dirk; Vik, Terry; Hanenberg, Helmut; Williams, David A.

In: Blood, Vol. 88, No. 3, 01.08.1996, p. 855-862.

Research output: Contribution to journalArticle

Moritz, Thomas ; Dutt, Parmesh ; Xiao, Xiangli ; Carstanjen, Dirk ; Vik, Terry ; Hanenberg, Helmut ; Williams, David A. / Fibronectin improves transduction of reconstituting hematopoietic stem cells by retroviral vectors : Evidence of direct viral binding to chymotryptic carboxy-terminal fragments. In: Blood. 1996 ; Vol. 88, No. 3. pp. 855-862.
@article{8226b5e70847407aaba2f767de9fb65d,
title = "Fibronectin improves transduction of reconstituting hematopoietic stem cells by retroviral vectors: Evidence of direct viral binding to chymotryptic carboxy-terminal fragments",
abstract = "Efficient transduction of reconstituting hematopoietic stem cells (HSC) is currently only possible by cocultivation of target cells directly on producer cell lines, a method not applicable to human gene therapy protocols. Our laboratory has previously shown adhesion of primitive hematopoietic stem and progenitor cells to the carboxy-terminal 30/35-kD fragment of the extracellular matrix molecule fibronectin (FN 30/35) (Nature 352:438, 1991) and increased transduction of human hematopoietic progenitor cells via retroviral vectors while adherent to this fragment (J Clin Invest 93:1451, 1994). Here we report that (1) transduction of reconstituting murine HSC assayed 12 months after infection with retrovirus supernatant on FN 30/35 is as effective as cocultivation directly on producer cells; (2) recombinant retrovirus particles directly adhere to FN 30/35 in a quantitative and dose-dependent fashion; and (3) increased transduction efficiency on FN 30/35 does not appear to be associated with increased cell proliferation or activation of protein phosphorylation typically induced by integrin-fibronectin interactions. Therefore, we speculate that supernatant infection of HSC on FN 30/35 leads to colocalization of retrovirus particles and target cells on FN 30/35 molecule with a large increase in local virus titer presented to the cell. These findings have direct and important implications for the modification of current human gene therapy protocols.",
author = "Thomas Moritz and Parmesh Dutt and Xiangli Xiao and Dirk Carstanjen and Terry Vik and Helmut Hanenberg and Williams, {David A.}",
year = "1996",
month = "8",
day = "1",
language = "English (US)",
volume = "88",
pages = "855--862",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "3",

}

TY - JOUR

T1 - Fibronectin improves transduction of reconstituting hematopoietic stem cells by retroviral vectors

T2 - Evidence of direct viral binding to chymotryptic carboxy-terminal fragments

AU - Moritz, Thomas

AU - Dutt, Parmesh

AU - Xiao, Xiangli

AU - Carstanjen, Dirk

AU - Vik, Terry

AU - Hanenberg, Helmut

AU - Williams, David A.

PY - 1996/8/1

Y1 - 1996/8/1

N2 - Efficient transduction of reconstituting hematopoietic stem cells (HSC) is currently only possible by cocultivation of target cells directly on producer cell lines, a method not applicable to human gene therapy protocols. Our laboratory has previously shown adhesion of primitive hematopoietic stem and progenitor cells to the carboxy-terminal 30/35-kD fragment of the extracellular matrix molecule fibronectin (FN 30/35) (Nature 352:438, 1991) and increased transduction of human hematopoietic progenitor cells via retroviral vectors while adherent to this fragment (J Clin Invest 93:1451, 1994). Here we report that (1) transduction of reconstituting murine HSC assayed 12 months after infection with retrovirus supernatant on FN 30/35 is as effective as cocultivation directly on producer cells; (2) recombinant retrovirus particles directly adhere to FN 30/35 in a quantitative and dose-dependent fashion; and (3) increased transduction efficiency on FN 30/35 does not appear to be associated with increased cell proliferation or activation of protein phosphorylation typically induced by integrin-fibronectin interactions. Therefore, we speculate that supernatant infection of HSC on FN 30/35 leads to colocalization of retrovirus particles and target cells on FN 30/35 molecule with a large increase in local virus titer presented to the cell. These findings have direct and important implications for the modification of current human gene therapy protocols.

AB - Efficient transduction of reconstituting hematopoietic stem cells (HSC) is currently only possible by cocultivation of target cells directly on producer cell lines, a method not applicable to human gene therapy protocols. Our laboratory has previously shown adhesion of primitive hematopoietic stem and progenitor cells to the carboxy-terminal 30/35-kD fragment of the extracellular matrix molecule fibronectin (FN 30/35) (Nature 352:438, 1991) and increased transduction of human hematopoietic progenitor cells via retroviral vectors while adherent to this fragment (J Clin Invest 93:1451, 1994). Here we report that (1) transduction of reconstituting murine HSC assayed 12 months after infection with retrovirus supernatant on FN 30/35 is as effective as cocultivation directly on producer cells; (2) recombinant retrovirus particles directly adhere to FN 30/35 in a quantitative and dose-dependent fashion; and (3) increased transduction efficiency on FN 30/35 does not appear to be associated with increased cell proliferation or activation of protein phosphorylation typically induced by integrin-fibronectin interactions. Therefore, we speculate that supernatant infection of HSC on FN 30/35 leads to colocalization of retrovirus particles and target cells on FN 30/35 molecule with a large increase in local virus titer presented to the cell. These findings have direct and important implications for the modification of current human gene therapy protocols.

UR - http://www.scopus.com/inward/record.url?scp=0029784888&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029784888&partnerID=8YFLogxK

M3 - Article

C2 - 8704241

AN - SCOPUS:0029784888

VL - 88

SP - 855

EP - 862

JO - Blood

JF - Blood

SN - 0006-4971

IS - 3

ER -